Company profile

Algocyte company profile

Algocyte offers an end-to-end medically-driven solution for remote blood testing and health monitoring. Algocyte enables medical professionals to remotely monitor their patients suffering from conditions such as leukemia and other types of cancer, as well as anemia, infection or inflammation, autoimmune, and other blood cell disorders. Algocyte is a medical device that can perform a variety of hematological and biochemical tests. Algocyte generates a more precise profile of an individual's health using all of the data collected than is possible using single snapshots, as is commonly done.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
00011-00050 employees
Founded
2019-01-01

Headquarters

Headquarters
Reading, England, United Kingdom
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
2
Total equity funding
$7.1M
Last funding
Seed / $7M / 2021-03-01
Last equity funding
Seed / $7M
Investors
1
Founders
1
Articles
1

Founders and investors

Founders

Hector Zenil

Investors

SFC Capital

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.